Clinical Trial Update: A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ABT-751 in combination with Taxotere in advanced non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ABT-751 (ABT-751)
• Taxotere (docetaxel)

Snippet

Sponsor: Abbott | Conditions: Lung Cancer, Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED